CD1A and myeloid leukemia: To further characterize the pool of CD1a-autoreactive T cells, Moody, and co-workers have recently designed an experimental system based on CD1-expressing human myelogenous leukemia cells (K562 cells), with low or absent expression of MHC molecules in order to limit allo-reactivity.